Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 36 Records) |
Query Trace: Lung Neoplasms and UGT1A1[original query] |
---|
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011 Jan 6 (1): 1. Nakamura Y, Soda H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi K, Masuda N, Tsukamoto K, Kohno S |
Prevalence of topoisomerase I genetic mutations and UGT1A1 polymorphisms associated with irinotecan in individuals of Asian descent. Oncology letters 2011 Sep 2 (5): 923-928. Fukui Tomoya, Mitsufuji Hisashi, Kubota Masaru, Inaoka Hidenori, Hirose Minoru, Iwabuchi Keiichi, Masuda Noriyuki, Kobayashi Hirosu |
Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy. Molecular and clinical oncology 2014 Sep 2 (5): 737-743. Harada Taishi, Saito Haruhiro, Karino Fumi, Isaka Tetsuya, Murakami Shuji, Kondo Tetsuro, Oshita Fumihiro, Miyagi Yohei, Yamada Kou |
Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers. Oncology letters 2014 Jun 7 (6): 2035-2040. Moriya Hiroyuki, Saito Katsuhiko, Helsby Nuala, Sugino Shigekazu, Yamakage Michiaki, Sawaguchi Takeru, Takasaki Masahiko, Kato Hidenori, Kurosawa Naho |
Uridine diphosphate glucuronide transferase 1A1FNx0128 gene polymorphism and the toxicity of irinotecan in recurrent and refractory small cell lung cancer. Journal of cancer research and therapeutics 2014 Nov 10 Suppl C195-200. Yun Fan, Lulu Miao, Zhiyu Huang, Lei Gong, Haifeng Yu, Tao Lei, Haiyan Yang, Conghua X |
[Association of UGT1A1 (*28, *60 and * 93) polymorphism with the adverse reactions of irinotecan chemotherapy in extensive stage small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2015 Jan 37 (1): 29-32. Ma Lixia, Chen Yan, Yang Changliang, Jiang Hui, Zhu Jing, Cheng Yi |
The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer. OncoTargets and therapy 2015 8 3575-83. Xiao Xiao-Guang, Xia Shu, Zou Man, Mei Qi, Zhou Lei, Wang Shu-Jing, Chen Yu |
Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial. Thoracic cancer 2015 Nov 6 (6): 785-91. Shi Yuankai, Hu Yi, Hu Xingsheng, Li Xue, Lin Lin, Han Xiaoho |
Successful treatment with afatinib after grade 3 hepatotoxicity induced by both gefitinib and erlotinib in EGFR mutation-positive non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2016 Sep 99 1-3. Zenke Yoshitaka, Umemura Shigeki, Sugiyama Eri, Kirita Keisuke, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Goto Koic |
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B). Thoracic cancer 2016 Jul 7 (4): 467-72. Fukuda Minoru, Suetsugu Takayuki, Shimada Midori, Kitazaki Takeshi, Hashiguchi Kohji, Kishimoto Junji, Harada Taishi, Seto Takashi, Ebi Noriyuki, Takayama Koichi, Sugio Kenji, Semba Hiroshi, Nakanishi Yoichi, Ichinose Yuki |
Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Thoracic cancer 2017 Jan 8 (1): 40-45. Fukuda Minoru, Shimada Midori, Kitazaki Takeshi, Nagashima Seiji, Hashiguchi Kohji, Ebi Noriyuki, Takayama Koichi, Nakanishi Yoichi, Semba Hiroshi, Harada Taishi, Seto Takashi, Okamoto Isamu, Ichinose Yukito, Sugio Ken |
Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population. International journal of clinical oncology 2016 Nov . Nishikawa Yoshitaka, Kanai Masashi, Narahara Maiko, Tamon Akiko, Brown J B, Taneishi Kei, Nakatsui Masahiko, Okamoto Kazuya, Uneno Yu, Yamaguchi Daisuke, Tomono Teruko, Mori Yukiko, Matsumoto Shigemi, Okuno Yasushi, Muto Mana |
UGT1A1 Gene Polymorphism Predicts Irinotecan-Induced Severe Neutropenia and Diarrhea in Chinese Cancer Patients. Clinical laboratory 2017 Sep 63 (9): 1339-1346. Peng Hongwei, Duan Zhouping, Pan Decheng, Wen Jinhua, Wei Xiaoh |
Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy. OncoTargets and therapy 2017 10 3071-3081. Bai Yu, Wu Hai-Wei, Ma Xu, Liu Ying, Zhang Yan-H |
UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis. Cancer chemotherapy and pharmacology 2017 Jun 79 (6): 1109-1117. Chen Xuewei, Liu Liping, Guo Zhihua, Liang Wenhua, He Jiaxi, Huang Liyan, Deng Qiuhua, Tang Hailing, Pan Hui, Guo Minzhang, Liu Yang, He Qihua, He Jianxi |
[Detection of UGT1A1*28 Polymorphism Using Fragment Analysis]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 12 20 (12): 817-821. Huang Ying, Su Jian, Huang Xiaosui, Lu Danxia, Xie Zhi, Yang Suqing, Guo Weibang, Lv Zhiyi, Wu Hongsui, Zhang Xuch |
Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer. Cancer chemotherapy and pharmacology 2018 01 81 (1): 81-87. Murakami Shuji, Saito Haruhiro, Kondo Tetsuro, Ito Hiroyuki, Oshita Fumihiro, Yamada Kou |
Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer. Thoracic cancer 2017 Oct . Fukuda Minoru, Okumura Manabu, Iwakiri Tomomi, Arimori Kazuhiko, Honda Takuya, Kobayashi Kazuma, Senju Hiroaki, Takemoto Shinnosuke, Ikeda Takaya, Yamaguchi Hiroyuki, Nakatomi Katsumi, Matsuo Nobuko, Mukae Hiroshi, Ashizawa Kazu |
Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer. Integrative cancer therapies 2018 9 17 (4): 1109-1114. Lu Hongyang, Qin Jing, Han Na, Xie Fajun, Gong Lei, Li Chengh |
Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients. Lung cancer (Amsterdam, Netherlands) 2018 12 126 156-161. Anai Satoshi, Iwama Eiji, Yoneshima Yasuto, Otsubo Kohei, Tanaka Kentaro, Nakanishi Yoichi, Okamoto Isa |
Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer. International journal of clinical oncology 2019 Mar 24 (3): 256-261. Negoro Yutaka, Yano Ryoichi, Yoshimura Mari, Suehiro Yoko, Yamashita Shinji, Kodawara Takaaki, Watanabe Kyohei, Tsukamoto Hitoshi, Nakamura Toshiaki, Kadowaki Maiko, Morikawa Miwa, Umeda Yukihiro, Anzai Masaki, Ishizuka Tamotsu, Goto Nobuyu |
Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters. Biological & pharmaceutical bulletin 2018 41 (1): 47-56. Endo-Tsukude Chihiro, Sasaki Ji-Ichiro, Saeki Sho, Iwamoto Norihiro, Inaba Megumi, Ushijima Sunao, Kishi Hiroto, Fujii Shinji, Semba Hiroshi, Kashiwabara Kosuke, Tsubata Yukari, Hayashi Mitsuhiro, Kai Yuki, Saito Hideyuki, Isobe Takeshi, Kohrogi Hirotsugu, Hamada Akino |
Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer. European review for medical and pharmacological sciences 2020 Oct 24 (19): 9973-9980. Han Z-F, Lin S-T, Zhong M, Yu D |
Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells 2021 Feb 10 (2): . Seyed Khoei Nazlisadat, Carreras-Torres Robert, Murphy Neil, Gunter Marc J, Brennan Paul, Smith-Byrne Karl, Mariosa Daniela, Mckay James, O'Mara Tracy A, Jarrett Ruth, Hjalgrim Henrik, Smedby Karin E, Cozen Wendy, Onel Kenan, Diepstra Arjan, Wagner Karl-Heinz, Freisling Hei |
UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan-Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall Survival. The oncologist 2021 Mar . Bandyopadhyay Ankan, Sharma Siddharth, Behera Digambar, Singh Navne |
Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer. Tumori 2021 12 107 (6): 536-541. Seto Zenta, Takata Naoki, Murayama Nozomu, Tokui Kotaro, Okazawa Seisuke, Kambara Kenta, Imanishi Shingo, Miwa Toshiro, Hayashi Ryuji, Matsui Shoko, Inomata Minehi |
UGT1A1 Gene Polymorphism Contributes as a Risk Factor for Lung Cancer: A Pilot Study with Patients from the Amazon. Genes 2022 3 13 (3): . Pereira Esdras E B, Leitão Luciana P C, Andrade Roberta B, Modesto Antônio A C, Fernandes Bruno M, Burbano Rommel M R, Assumpção Paulo P, Fernandes Marianne R, Guerreiro João F, Santos Sidney E B Dos, Santos Ney P C D |
The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients. Genomics & informatics 2022 Sep 20 (3): e29. Lee Choong-Kun, Chon Hong Jae, Kwon Woo Sun, Ban Hyo-Jeong, Kim Sang Cheol, Kim Hyunwook, Jeung Hei-Cheul, Chung Jimyung, Rha Sun You |
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study. Thoracic cancer 2023 9 . Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, Takaya Ikeda, Seiji Nagashima, Kazumasa Akagi, Sawana Ono, Yasuhiro Umeyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Yasushi Hisamatsu, Ryotaro Morinaga, Ryuta Tagawa, Ryosuke Ogata, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Katsumi Nakatomi, Fumiko Hayashi, Nanae Sugasaki, Akitoshi Kinoshita, Hiroshi Muk |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: